BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 17079196)

  • 61. Assignment of xeroderma pigmentosum group C (XPC) gene to chromosome 3p25.
    Legerski RJ; Liu P; Li L; Peterson CA; Zhao Y; Leach RJ; Naylor SL; Siciliano MJ
    Genomics; 1994 May; 21(1):266-9. PubMed ID: 8088800
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.
    Mukhopadhyay A; Nikopoulos K; Maugeri A; de Brouwer AP; van Nouhuys CE; Boon CJ; Perveen R; Zegers HA; Wittebol-Post D; van den Biesen PR; van der Velde-Visser SD; Brunner HG; Black GC; Hoyng CB; Cremers FP
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3565-72. PubMed ID: 16877430
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Novel mutations of XPC gene detected in a family affected with xeroderma pigmentosum group C].
    Wang L; Huang S; Li J; Zou Y; Xu P; Gao M; Kang R; Xie H; Wei X; Niu Y; Liu X; Gao Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):540-543. PubMed ID: 30098252
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mutations in the Trp53 gene of UV-irradiated Xpc mutant mice suggest a novel Xpc-dependent DNA repair process.
    Nahari D; McDaniel LD; Task LB; Daniel RL; Velasco-Miguel S; Friedberg EC
    DNA Repair (Amst); 2004 Apr; 3(4):379-86. PubMed ID: 15010313
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Xeroderma pigmentosum group C splice mutation associated with autism and hypoglycinemia.
    Khan SG; Levy HL; Legerski R; Quackenbush E; Reardon JT; Emmert S; Sancar A; Li L; Schneider TD; Cleaver JE; Kraemer KH
    J Invest Dermatol; 1998 Nov; 111(5):791-6. PubMed ID: 9804340
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Insulin-like growth factors II exon 9 and E-cadherin-Pml I but not myeloperoxidase promoter-463, urokinase-ApaL I nor xeroderma pigmentosum polymorphisms are associated with higher susceptibility to leiomyoma.
    Hsieh YY; Chang CC; Wang YK; Hsu KH; Chen CP; Hsu CM; Tsai FJ
    Anticancer Res; 2010 Jun; 30(6):2203-8. PubMed ID: 20651370
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Functional lentiviral vectors for xeroderma pigmentosum gene therapy.
    Marchetto MC; Correa RG; Menck CF; Muotri AR
    J Biotechnol; 2006 Dec; 126(4):424-30. PubMed ID: 16857285
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Xeroderma pigmentosum group C protein interacts physically and functionally with thymine DNA glycosylase.
    Shimizu Y; Iwai S; Hanaoka F; Sugasawa K
    EMBO J; 2003 Jan; 22(1):164-73. PubMed ID: 12505994
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
    Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
    Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Structural, thermodynamic, and cellular characterization of human centrin 2 interaction with xeroderma pigmentosum group C protein.
    Charbonnier JB; Renaud E; Miron S; Le Du MH; Blouquit Y; Duchambon P; Christova P; Shosheva A; Rose T; Angulo JF; Craescu CT
    J Mol Biol; 2007 Nov; 373(4):1032-46. PubMed ID: 17897675
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family.
    Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M
    Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer.
    Raaschou-Nielsen O; Sørensen M; Overvad K; Tjønneland A; Vogel U
    Lung Cancer; 2008 Feb; 59(2):171-9. PubMed ID: 17913280
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Overproduction of DNA polymerase eta does not raise the spontaneous mutation rate in diploid human fibroblasts.
    King NM; Nikolaishvili-Feinberg N; Bryant MF; Luche DD; Heffernan TP; Simpson DA; Hanaoka F; Kaufmann WK; Cordeiro-Stone M
    DNA Repair (Amst); 2005 Jun; 4(6):714-24. PubMed ID: 15886068
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor.
    Gozukara EM; Khan SG; Metin A; Emmert S; Busch DB; Shahlavi T; Coleman DM; Miller M; Chinsomboon N; Stefanini M; Kraemer KH
    J Invest Dermatol; 2001 Aug; 117(2):197-204. PubMed ID: 11511294
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
    De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
    Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
    [TBL] [Abstract][Full Text] [Related]  

  • 76. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk.
    Liu G; Zhou W; Yeap BY; Su L; Wain JC; Poneros JM; Nishioka NS; Lynch TJ; Christiani DC
    Carcinogenesis; 2007 Jun; 28(6):1254-8. PubMed ID: 17264068
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mutational inactivation of the xeroderma pigmentosum group C gene confers predisposition to 2-acetylaminofluorene-induced liver and lung cancer and to spontaneous testicular cancer in Trp53-/- mice.
    Cheo DL; Burns DK; Meira LB; Houle JF; Friedberg EC
    Cancer Res; 1999 Feb; 59(4):771-5. PubMed ID: 10029060
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genotype-phenotype correlation of xeroderma pigmentosum in a Chinese Han population.
    Sun Z; Zhang J; Guo Y; Ni C; Liang J; Cheng R; Li M; Yao Z
    Br J Dermatol; 2015 Apr; 172(4):1096-102. PubMed ID: 25256075
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of new EBV-based vectors for stable expression of small interfering RNA to mimick human syndromes: application to NER gene silencing.
    Biard DS; Despras E; Sarasin A; Angulo JF
    Mol Cancer Res; 2005 Sep; 3(9):519-29. PubMed ID: 16179499
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of Big Data to Estimate Prevalence of Defective DNA Repair Variants in the US Population.
    Pugh J; Khan SG; Tamura D; Goldstein AM; Landi MT; DiGiovanna JJ; Kraemer KH
    JAMA Dermatol; 2019 Jan; 155(1):72-78. PubMed ID: 30516811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.